Zinc Therapy for Alzheimer's Disease
Author Information
Author(s): Tjaard U. Hoogenraad
Primary Institution: University Medical Centre, Utrecht
Hypothesis
Age related free copper toxicosis is a causal factor in pathogenesis of Alzheimer's disease.
Conclusion
Oral zinc therapy is a safe and effective treatment for free copper toxicosis in Alzheimer's disease.
Supporting Evidence
- Zinc therapy has been shown to improve cognitive functions in some Alzheimer's patients.
- Free copper levels are elevated in Alzheimer's disease patients, correlating with worse clinical outcomes.
- Previous studies suggest that zinc can counteract the harmful effects of copper in the body.
Takeaway
This study suggests that giving zinc to people with Alzheimer's might help because too much copper in their bodies can be harmful.
Methodology
The review cumulates evidence from various studies on copper metabolism and zinc therapy in Alzheimer's disease.
Potential Biases
Potential bias in interpreting the effects of zinc therapy due to limited studies.
Limitations
The conclusions about zinc therapy are based on preliminary studies and require further investigation.
Participant Demographics
The study references findings from various populations but does not specify participant demographics.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website